Related Experiment Video
Updated: May 25, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome
Giustina Ferone1, Helen A Thomason, Dario Antonini
1Fondazione IRCCS SDN, Napoli, Italy.
Insights
A new mouse model for Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome reveals p63 mutations impair skin development by disrupting fibroblast growth factor (FGF) signaling. Restoring FGF signaling in affected cells promotes proliferation, offering insights into AEC pathogenesis.
Area of Science:
- Developmental Biology
- Genetics
- Cell Biology
Background:
- Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome is an autosomal dominant disorder linked to p63 gene mutations.
- The syndrome causes cleft palate and severe skin defects, impacting ectodermal development.
Purpose of the Study:
- To generate and characterize a knock-in mouse model for AEC syndrome.
- To elucidate the molecular mechanisms underlying AEC syndrome pathogenesis, focusing on p63 function and signaling pathways.
Main Methods:
- Generation of a p63 knock-in mouse model (p63(+/L514F)) mimicking human AEC syndrome.
- Analysis of progenitor cell expansion, epidermal stem cell compartment, and gene expression (Fgfr2, Fgfr3).
- Investigating the role of fibroblast growth factor (FGF) signaling by treating cells with FGF7.
Main Results:
- The p63(+/L514F) mouse model recapitulates human AEC syndrome phenotypes.
- AEC mutation causes dominant-negative effects on p63, impairing ectodermal progenitor cell expansion and epidermal stem cell function.
- Impaired FGF signaling due to reduced Fgfr2 and Fgfr3 expression was observed, directly linked to p63 targets.
- Restoring Fgfr2b expression via FGF7 treatment reactivated MAPK signaling and cell proliferation in affected cells.
Conclusions:
- A functional link exists between FGF signaling and p63 in epithelial progenitor cell expansion.
- The study provides mechanistic insights into AEC syndrome pathogenesis, highlighting the critical role of the p63-FGF signaling axis.
- The mouse model serves as a valuable tool for studying AEC syndrome and related developmental disorders.
Abstract:
Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, which is characterized by cleft palate and severe defects of the skin, is an autosomal dominant disorder caused by mutations in the gene encoding transcription factor p63. Here, we report the generation of a knock-in mouse model for AEC syndrome (p63(+/L514F) ) that recapitulates the human disorder. The AEC mutation exerts a selective dominant-negative function on wild-type p63 by affecting progenitor cell expansion during ectodermal development leading to a defective epidermal stem cell compartment. These phenotypes are associated with impairment of fibroblast growth factor (FGF) signalling resulting from reduced expression of Fgfr2 and Fgfr3, direct p63 target genes. In parallel, a defective stem cell compartment is observed in humans affected by AEC syndrome and in Fgfr2b(-/-) mice. Restoring Fgfr2b expression in p63(+/L514F) epithelial cells by treatment with FGF7 reactivates downstream mitogen-activated protein kinase signalling and cell proliferation. These findings establish a functional link between FGF signalling and p63 in the expansion of epithelial progenitor cells and provide mechanistic insights into the pathogenesis of AEC syndrome.
Related Concept Videos
Abnormal Proliferation
Pleiotropy
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Hedgehog Signaling Pathway
Mitogens and the Cell Cycle
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

